DISC1 and Reelin interact to alter cognition, inhibition, and neurogenesis in a novel mouse model of schizophrenia
Heather Mahoney(University of South Florida), Danielle Gulick(University of South Florida), Hannah Justin(University of South Florida), Bethany Carter(University of South Florida), April L. Lussier(University of South Florida), Christopher Morris(University of South Florida), Joshua J. Gamsby(University of South Florida), Bianca M. Capraro(University of South Florida), Emily Sandefur(University of South Florida), Angie Ocampo(University of South Florida), David González de Castro(Complejo Hospitalario de Salamanca), Samantha L. Reiss(University of South Florida), L. Dinh(University of South Florida), Charissa A. Bloom(University of South Florida), Edwin J. Weeber(Society for Neuroscience), Angel F. Valladares(IQVIA (United States))
Cited by 0
Related Papers
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
|The Lancet Oncology|2013|728
CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity
|Journal of Neuroscience|2011|633
Reelin and ApoE Receptors Cooperate to Enhance Hippocampal Synaptic Plasticity and Learning
|Journal of Biological Chemistry|2002|629